Chemfab Alkalis Successfully Commissions New Ineos Electrolyser with ₹57 Crore Investment
Chemfab Alkalis Ltd has officially commissioned a new latest generation Ineos electrolyser system, replacing 30-year-old UHDE equipment with a ₹57 crore investment funded through internal accruals. The company expects enhanced operating rates, better reliability, and significant power savings from Q4 FY26 while maintaining consent capacity at 180 tonnes per day.

*this image is generated using AI for illustrative purposes only.
Chemfab Alkalis Ltd has successfully commissioned a new Ineos electrolyser system, marking the completion of a significant technological upgrade in its manufacturing operations. The company officially announced the commissioning under Regulation 30 of SEBI listing requirements, confirming the replacement of equipment that had been operational for 30 years.
Investment and Equipment Details
The modernization project represents a substantial capital commitment financed entirely through internal resources:
| Investment Parameter: | Details |
|---|---|
| Total Capital Expenditure: | ₹57.00 crores |
| Financing Source: | Internal accruals |
| New Equipment: | Latest generation Ineos electrolyser |
| Replaced Equipment: | 30-year-old 2nd-Generation UHDE electrolyser |
| Consent Capacity: | 180 tonnes per day |
Expected Operational Benefits
The company anticipates multiple operational improvements from this equipment upgrade. The new Ineos electrolyser is expected to deliver enhanced operating rates with better reliability compared to the previous system. Additionally, the modern technology is projected to generate significant power savings, contributing to improved operational efficiency and cost optimization.
Implementation Timeline and Capacity
Chemfab Alkalis expects the benefits from this technological upgrade to become apparent starting from the fourth quarter of fiscal year 2026. The consent capacity remains unchanged at 180 tonnes per day, ensuring continuity in production capabilities while enhancing efficiency parameters.
Strategic Significance
The successful commissioning demonstrates the company's commitment to technological advancement and operational excellence. By financing this major capital expenditure through internal accruals, Chemfab Alkalis showcases its strong financial position and strategic focus on modernizing its chemical manufacturing operations for enhanced competitiveness.
Historical Stock Returns for Chemfab Alkalis
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.35% | +6.36% | -12.42% | -45.02% | -57.24% | +193.84% |


































